GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Current Deferred Revenue

Daxor (FRA:DX5) Current Deferred Revenue


View and export this data going back to 2021. Start your Free Trial

What is Daxor Current Deferred Revenue?

Current Deferred Revenue does not apply to banks.


Daxor Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Daxor's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Daxor (FRA:DX5) Business Description

Traded in Other Exchanges
Address
109 Meco Lane, Oak Ridge, TN, USA, 37830
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.